RY 133.21 -0.0675% TD 78.64 0.4599% SHOP 95.75 0.136% CNR 174.55 -0.2172% ENB 46.51 1.3511% CP 115.18 -0.3375% BMO 125.12 -0.1197% TRI 207.83 -1.3153% CNQ 105.4 -0.8467% BN 52.885 -1.5544% ATD 75.13 -0.186% CSU 3670.4399 -1.1052% BNS 64.03 -0.2959% CM 64.91 0.1698% SU 52.315 0.2587% TRP 48.59 0.5796% NGT 53.03 -0.0942% WCN 226.63 -0.0838% MFC 31.51 0.2226% BCE 44.31 -0.2476%

Leveljump Healthcare Corp

Healthcare CA JUMP

0.075CAD
-(-%)

Last update at 2024-04-18T18:04:00Z

Day Range

0.070.08
LowHigh

52 Week Range

0.040.12
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Type yearly yearly yearly yearly yearly
Date 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Income before tax 0.23M -2.22899M -0.12875M - -
Minority interest - - - - -
Net income 0.23M -2.22899M -0.12875M - -
Selling general administrative 3.06M 3.52M 0.13M - -
Selling and marketing expenses - - - - -
Gross profit 2.49M 1.35M 1.04M - -
Reconciled depreciation 0.21M 0.03M 0.03M - -
Ebit - -2.19686M -2.14975M 0.21M -0.02096M
Ebitda 0.59M -2.15758M -0.12875M - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.77504M -2.19686M -0.12875M - -
Other operating expenses - - - - -
Interest expense 0.14M 0.04M 0.08M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.14314M -0.03782M -0.08121M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 9.23M 6.72M 5.46M - -
Total operating expenses 10.00M 8.92M 0.13M - -
Cost of revenue 6.74M 5.37M 4.41M - -
Total other income expense net 1.15M 0.00569M -11.45324M - -
Discontinued operations - - - - -
Net income from continuing ops 0.23M -2.22899M -0.12875M - -
Net income applicable to common shares - -2.22899M -11.56304M 0.11M -0.10700M
Preferred stock and other adjustments - - - - -
Breakdown 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Type yearly yearly yearly yearly yearly
Date 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Total assets 13.26M 4.10M 0.24M 0.14M -
Intangible assets 6.07M - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 6.99M 2.12M 0.04M 0.03M -
Total stockholder equity 6.27M 1.98M 0.20M 0.11M -
Deferred long term liab - - - - -
Other current liab - - 0.34M 0.08M -
Common stock - 12.88M 10.98M 0.13M 0.00001M
Capital stock 15.62M 12.88M 10.98M 0.15M -
Retained earnings -14.40679M -14.64156M -12.41258M -0.84953M -0.95551M
Other liab - 0.22M 0.12M - -
Good will - - - - -
Other assets - - - - -
Cash 0.08M 0.76M 0.91M - -
Cash and equivalents - - - - -
Total current liabilities 2.96M 1.90M 1.43M 1.36M 1.43M
Current deferred revenue - - - - -
Net debt 3.83M - - - -
Short term debt - - - - -
Short long term debt 0.51M - - - -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - 0.04M 0.05M 0.08M 0.02M
Total current assets 3.37M 3.95M 1.92M 0.62M 0.52M
Long term investments 2.52M 0.10M - - -
Net tangible assets - 1.98M 0.33M -0.71886M -0.91634M
Short term investments - 1.33M - - -
Net receivables 1.36M 1.44M 0.65M 0.61M 0.51M
Long term debt 3.39M - 0.06M - -
Inventory - - - - -
Accounts payable 1.27M 1.87M 0.92M 1.04M 1.13M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 9.89M 0.15M 0.05M 0.00000M -
Capital lease obligations 0.27M 0.03M 0.06M - -
Long term debt total - - - - -
Breakdown 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Type yearly yearly yearly yearly yearly
Date 2022-08-31 2021-08-31 2020-08-31 2019-08-31 2018-08-31
Investments -5.82484M -0.02547M 0.14M 0.14M 0.14M
Change to liabilities - -0.03980M -0.17304M 0.03M -0.20187M
Total cashflows from investing activities - -0.02547M 0.35M -0.00424M -0.01921M
Net borrowings - 0.06M 0.10M -0.01344M -0.09299M
Total cash from financing activities 5.46M 1.64M 3.54M -0.17271M 0.20M
Change to operating activities - -0.13042M -0.43768M 0.00137M -0.00408M
Net income 0.23M -2.22899M -11.56304M 0.11M -0.10700M
Change in cash -0.67330M -0.14929M 0.91M 0.07M -0.05475M
Begin period cash flow 0.76M 0.91M 0.12M - -
End period cash flow 0.08M 0.76M 0.22M 0.12M -
Total cash from operating activities -0.31118M -1.76598M -2.98513M 0.24M -0.23058M
Issuance of capital stock 2.52M 1.60M 0.23M - -
Depreciation 0.21M 0.03M 0.03M 0.06M 0.01M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.48016M -0.16589M -0.03248M -0.00693M 0.07M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -0.04906M -0.00084M -0.15926M 0.29M
Change to netincome - 0.77M 9.19M 0.05M 0.00512M
Capital expenditures 1.65M 0.03M 0.00000M 0.00424M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.02943M -0.33610M -0.00072M - -
Stock based compensation 0.29M 0.74M 0.04M - -
Other non cash items -1.02185M 0.01M 9.12M - -
Free cash flow -1.95849M -1.79145M -0.09183M - -

Fundamentals

  • Previous Close 0.07
  • Market Cap9.17M
  • Volume10000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.49456M
  • Revenue TTM11.63M
  • Revenue Per Share TTM0.13
  • Gross Profit TTM 1.35M
  • Diluted EPS TTM-

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
JUMP
Leveljump Healthcare Corp
- -% 0.07 - - 0.79 1.52 1.42 19.92
AVCR
Avricore Health Inc
0.005 3.57% 0.14 - - 5.45 9.38 5.33 -26.0936
TELO
Telo Genomics Corp
-0.045 20.00% 0.18 - - - 5.76 -3.3322

Reports Covered

Stock Research & News

Profile

Leveljump Healthcare Corp., together with its subsidiaries, operates as a medical diagnostic imaging company. The company provides teleradiology services to its client hospitals. It also owns and operates imaging centers. Leveljump Healthcare Corp. is headquartered in Toronto, Canada.

Leveljump Healthcare Corp

85 Scarsdale Road, Toronto, ON, Canada, M3B 2R2

Key Executives

Name Title Year Born
Mr. Mitchell Geisler Pres, CEO & Chairman 1970
Mr. Robert Landau CFO, Corp. Sec. & Director 1971

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).